Drugs / KHN707
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07557537 | May → Oct 2026 expected | — | Chengdu Kanghong Pharmaceutical Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KHN707 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07557537 ↗ |
| Route | Oral | “orally” NCT07557537 ↗ |